[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Moody, 1982 - Google Patents

Plasminogen in human saliva

Moody, 1982

Document ID
11544630375999061633
Author
Moody G
Publication year
Publication venue
International Journal of Oral Surgery

External Links

Snippet

Plasminogen has been demonstrated in human parotid, submandibular and whole saliva both immunologically and functionally by activation with streptokinase. There was a significantly higher level of plasminogen in whole saliva than in either parotid or …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms

Similar Documents

Publication Publication Date Title
Aoki et al. Congenital deficiency of α 2-plasmin inhibitor associated with severe hemorrhagic tendency
Rent et al. Potentiation of C1-esterase inhibitor activity by heparin
Crutchley et al. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
Hasday et al. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis
EP0203509B1 (en) Method for the quantitative determination of protein-C and an activating preparation for its implementation.
Mannucci et al. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate
Hedner Studies on an inhibitor of plasminogen activation in human serum
White et al. Toxicity of human hemoglobin solution infused into rabbits
Huseby et al. Synthetic Oligopeptide Substrates Their Diagnostic Application in Blood Coagulation, Fibrinolysis, and Other Pathologic States
McKenzie et al. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen
Moody Plasminogen in human saliva
Malinconico et al. Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianii
Kisker et al. Detection of intravascular coagulation
Harpel Studies on the Interaction between Collagen and a Plasma Kallikrein-Like Activity EVIDENCE FOR A SURFACE-ACTIVE ENZYME SYSTEM
Toki et al. Urinary trypsin inhibitor and urokinase activities in renal diseases
Marder et al. Changes in the plasma fibrinolytic system during urokinase therapy: comparison of tissue culture urokinase with urinary source urokinase in patients with pulmonary embolism
Mui et al. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum
Jenzano et al. Levels of glandular kallikrein in whole saliva obtained from patients with solid tumors remote from the oral cavity
Silberman et al. Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity
US4849406A (en) Method for promoting epithelial healing and prevention of epitheliam destruction
Forrester et al. Enhancement of vitreous clot lysis by urokinase: mode of action
Fisher et al. Stimulation of collagenase secretion from rheumatoid synovial tissue by human collagen peptides.
Gans et al. Problems in hemostasis during open heart surgery. IX. Changes observed in the plasminogen-plasmin system and their significance for therapy.
Jacobsen Proteolytic Capacity in Human Plasma Part I Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations
Sala et al. Dysfunctional activated protein C (PC Cadiz) in a patient with thrombotic disease